AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chin, S. E.
Right arrow Articles by Strong, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chin, S. E.
Right arrow Articles by Strong, R.
Agricola
Right arrow Articles by Chin, S. E.
Right arrow Articles by Strong, R.

American Journal of Clinical Nutrition, Vol 56, 158-163, Copyright © 1992 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement

SE Chin, RW Shepherd, BJ Thomas, GJ Cleghorn, MK Patrick, JA Wilcox, TH Ong, SV Lynch and R Strong
Queensland Liver Transplant Service, Royal Children's Hospital, Brisbane, Australia.

Malnutrition is common in children with end-stage liver disease (ESLD) awaiting orthotopic liver transplantation (OLT), and nutritional support is assuming an important role in preoperative management. To evaluate preoperative nutritional therapy, 19 children (median age 1.25 y) with ESLD awaiting OLT were prospectively studied. Two high-energy, isoenergetic and isonitrogenous nutritional formulations delivered nasogastrically were compared: a branched-chain amino acid (BCAA)- enriched semielemental formulation and a matched standard semielemental formation. Twelve of 19 patients completed a randomized controlled study before OLT and 10 of 19 completed a full crossover study. Improvements in weight and height occurred during the BCAA supplements, with no statistical change on the standard formulation. Significant increases in total body potassium, midupper arm circumference, and subscapular skinfold thickness occurred during the BCAA supplements, whereas no significant changes occurred during the standard formulation period. Significantly fewer albumin infusions were required during the BCAA supplement. These findings suggest that BCAA-enriched formulas have advantages over standard semielemental formulas in improving nutritional status in children with ESLD, and are deserving of wider application and study.


This article has been cited by other articles:


Home page
J. Nutr.Home page
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz
Mild-to-Moderate Chronic Cholestatic Liver Disease Increases Leucine Oxidation in Children
J. Nutr., April 1, 2006; 136(4): 965 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. R. Mager, L. J. Wykes, E. A. Roberts, R. O. Ball, and P. B. Pencharz
Branched-Chain Amino Acid Needs in Children with Mild-to-Moderate Chronic Cholestatic Liver Disease
J. Nutr., January 1, 2006; 136(1): 133 - 139.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. Marchesini, R. Marzocchi, M. Noia, and G. Bianchi
Branched-Chain Amino Acid Supplementation in Patients with Liver Diseases
J. Nutr., June 1, 2005; 135(6): 1596S - 1601S.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. D. Wallace, W. J. Abbott-Johnson, D. H. G. Crawford, R. Barnard, J. M. Potter, and R. C. Cuneo
GH Treatment in Adults with Chronic Liver Disease: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2751 - 2759.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by The American Society for Nutrition